Artemisinin kinetics and dynamics during oral and rectal treatment of uncomplicated malaria

Clinical Pharmacology and Therapeutics

Volumn 63, Issue 4, 1998, Pages 482-493

  Ashton, Michael ^a   Sy, Nguyen Duy ^b   Van Huong, Nguyen ^b   Gordi, Toufigh ^b   Hai, Trinh Ngoc ^b   Huong, Dinh Xuan ^b   Niêu, Nguyen Thi ^b   Công, Le Dinh ^b  

^a UPPSALA UNIVERSITY   (Sweden)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; ARTEMISININ; DIAZEPAM; PARACETAMOL;

ADULT; AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG ELIMINATION; DRUG PROTEIN BINDING; HUMAN; MALARIA FALCIPARUM; MALE; ORAL DRUG ADMINISTRATION; PATIENT COMPLIANCE; PHARMACODYNAMICS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECTAL DRUG ADMINISTRATION;

ADMINISTRATION, ORAL; ADMINISTRATION, RECTAL; ADULT; ANTIMALARIALS; AREA UNDER CURVE; ARTEMISININS; HUMANS; MALARIA; MALE; MIDDLE AGED; SESQUITERPENES; TIME FACTORS; VIETNAM;

EID: 0031954715     PISSN: 00099236     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-9236(98)90044-3     Document Type: Article

References (33)

1. Klayman DL. Qinghaosu (artemisinin): an antimalarial drug from China. Science 1985;228:1049-55.
2. Hien TT, White NJ. Qinghaosu. Lancet 1993;341:603-8.
3. Meshnick SR, Taylor TE, Kamchonwongpaisan S. Artemisinin and the antimalarial endoperoxides: from herbal remedy to targeted chemotherapy. Microbiol Rev 1996;60:301-15.
4. Nguyen DS, Dao BH, Nguyen PD, Nguyen VH, Le NB, Mai VS, et al. Treatment of malaria in Vietnam with oral artemisinin. Am J Trop Med Hyg 1993;48:398-402.
5. Hien TT. An overview of the clinical use of artemisinin and its derivatives in the treatment of falciparum malaria in Viet Nam. Trans R Soc Trop Med Hyg 1994; 88(suppl 1):7-8.
6. Ashton M, Sy ND, Gordi T, Hai TN, Thach DC, Huong NV, et al. Evidence for time-dependent artemisinin kinetics in adults with uncomplicated malaria. Pharm Pharmacol Lett 1996;6:127-30.
7. Hassan Alin M, Ashton M, Kihamia CM, Mtey GJB, Björkman A. Multiple dose pharmacokinetics of oral artemisinin and comparison of its efficacy with that of oral artesunate in falciparum malaria patients. Trans R Soc Trop Med Hyg 1996;90:61-5.
8. Hassan Alin M, Ashton M, Kihamia CM, Mtey GJB, Björkman A. Clinical efficacy and pharmacokinetics of artemisinin monotherapy and in combination with mefloquine in patients with falciparum malaria. Br J Clin Pharmacol 1996;41:587-92.
9. Riegelman S, Collier P. The application of statistical moment theory to the evaluation of in vivo dissolution time and absorption time. J Pharmacokinet Biopharm 1980;8:509-34.
10. Edlund PO, Westerlund D, Carlqvist J, Bo-Liang W, Yunhua J. Determination of artesunate and dihydroartemisinine in plasma by liquid chromatography with post-column derivatization and UV-detection. Acta Pharm Suec 1984;21:223-34.
11. Shah VP, Midha KK, Dighe S, McGilveray IJ, Skelly JP, Yacobi A, et al. Analytical methods validation: bioavailability, bioequivalence and pharmacokinetic studies. Pharm Res 1992;9:588-92.
12. Perrier D, Meyersohn M. Noncompartmental determination of the steady-state volume of distribution for any mode of administration. J Pharm Sci 1982;71:372-3.
13. Li G, Guo X, Jian H, Fu L, Shen L, Li R, et al. Observation on the efficacy of qinghaosu suppository in 100 cases of falciparum malaria. J Tradit Chin Med 1985;5:159-61.
14. Arnold K, Hien TT, Chinh NT, Phu NH, Mai PP. A randomized comparative study of artemisinin (qinghaosu) suppositories and oral quinine in acute falciparum malaria. Trans R Soc Trop Med Hyg 1990;84:499-502.
15. Hien TT, Tam DTH, Cue NTK, Arnold K. Comparative effectiveness of artemisinin suppositories and oral quinine in children with acute falciparum malaria. Trans R Soc Trop Med Hyg 1991;85:210-1.
16. Hien TT, Arnold K, Vinh H, Loc PP, Dung NT, Cuong BM, et al. Comparison of artemisinin suppositories with intravenous artesunate and intravenous quinine in the treatment of cerebral malaria. Trans R Soc Trop Med Hyg 1992;86:582-3.
17. Looareesuwan S, Wilairatana P, Vanijanonta S, Viravan C, Andrial M. Efficacy and tolerability of a sequential, artesunate suppository plus mefloquine, treatment of severe falciparum malaria. Ann Trop Med Parasitol 1995;89:469-75.
18. Trentholme GM, Williams RL, Rieckmann KH, Frischer H, Carson PE. Quinine disposition during malaria and during induced fever. Clin Pharmacol Ther 1976;19:459-67.
19. Abdel-Razzak Z, Loyer P, Fautrel A, Gautier JC, Corcos L, Turlin B, et al. Cytokines down-regulate expression of major cytochrome P-450 enzymes in adult human hepatocytes in primary culture. Mol Pharmacol 1993;44:707-15.
20. Glazier AP, Kokwaro GG, Edwards G. Possible isozymespecific effects of experimental malaria infection with plasmodium berghei on cytochrome P450 activity in rat liver microsomes. J Pharm Pharmacol 1994;46:352-5.
21. Ashton M, Hai TN, Sy ND, Huong DX, Huong NV, Niêu NT, Công LD. Artemisinin pharmacokinetics is time-dependent in healthy subjects. Drug Metab Dispos 1998;26:25-7.
22. Svensson USH, Ashton M, Hai TN, Huong DX, Huong NV, Bertilsson L, et al. Artemisinin induces omeprazole metabolism in man. Clin Pharmacol Ther [in press].
23. Zhu DY, Huang BS, Chen ZL, Yin ML, Yang YM, Dai ML, et al. [Isolation and identification of the metabolite of artemisinine in human]. Chung Kuo Yao Li Hsueh Pao 1983;4:194-7.
24. Karbwang J, Na-Bangchang K, Thanavibul A, Back DJ, Bunnag D, Harinasuta T. Pharmacokinetics of mefloquine alone or in combination with artesunate. Bull World Health Organ 1994;72:83-7.
25. Na-Bangchang K, Karbwang J, Molunto P, Banmairurio V, Thanavibul A. Pharmacokinetics of mefloquine when given alone and in combination with artemether in patients with uncomplicated falciparum malaria. Fundam Clin Pharmacol 1995;9:576-82.
26. Titulaer HAC, Zuidema J, Kager PA, Wetsteyn JCFM, Lugt ChB, Merkus FWHM. The pharmacokinetics of artemisinin after oral, intramuscular and rectal administration to volunteers. J Pharm Pharmacol 1990;42:810-3.
27. Sidhu JS, Ashton M. Single-dose comparative study of venous, capillary and salivary artemisinin concentrations in healthy male, adults. Am J Trop Med Hyg 1997;56:13-6.
28. Li WH, Shu HL, Xu GY, Zeng YL. The binding of qinghaosu (artemisinine) and its derivatives to plasma protein. Acta Pharm Sin 1982;17:783-6.
29. Wanwimolruk S, Edwards G, Ward S, Breckenridge AM. The binding ot the antimalarial arteether to human plasma protein in vitro. J Pharm Pharmacol 1992;44:940-2.
30. 1Acid glycoprotein (orosomucoid) and plasma protein binding of quinine in falciparum malaria. Br J Clin Pharmacol 1991;32:311-5.
31. MacPherson GG, Warrell MJ, White NJ, Looareesuwan S, Warrell DA. Human cerebral malaria: a quantitative ultrastructural analysis of parasitized erythrocyte sequestration. Am J Pathol 1985;119:385-401.
32. Looareesuwan S, White NJ, Chittamas S, Bunnag D, Harinsuta T. High rate of plasmodium vivax relapse following treatment of falciparum malaria in Thailand. Lancet 1987;2:1052-5.
33. Phillips RE, Looareesuwan S, Warell DA, Lee SH, Karb-wang J, Warrell MJ, et al. The importance of anemia in cerebral and uncomplicated falciparum malaria: role of complications, dyserythropoiesis and iron sequestration. Q J Med 1986;227:305-23.